An official from the exchange explained, "The KOSDAQ pharmaceutical sector, which has a large number of individual investors, also saw its operating profit drop by 7.0% compared to the same period last year."
거래소 관계자는 "개인투자자가 많은 코스닥 제약 분야도 영업이익이 작년 동기 대비 7.0%가량 감소했다"고 설명했다.